Gold steadies as vaccine doubts weigh on recovery outlook

Gold was down over 3% for the week as progress in COVID-19 vaccine development and U.S. President-elect Joe Biden's transition to the White House bolstered risk sentiment.

from Commodities-Markets-Economic Times
Read The Rest:economictimes...